Kids received mental health treatment in record numbers after pandemic, records show

by Tim Schley, Pennsylvania State University

edited by Stephanie Baum, reviewed by Andrew Zinin

Stephanie Baum

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

The GIST Add as preferred source

When schools closed in the spring of 2020 at the onset of the COVID-19 pandemic, the number of children and adolescents receiving mental health treatment in the United States fell by more than half. By 2022, that number had not only rebounded, it exceeded pre-pandemic levels, according to a new national study by researchers from Penn State College of Medicine.

In an analysis of 13 million health records of children and adolescents, appearing in JAACAP Open, the researchers found that the rise in pediatric mental health treatment patterns was driven largely by new patients rather than existing patients seeking more care. Rates of first-time prescriptions for psychiatric medication increased by 35%, outpacing the rise in both first-time psychiatric diagnoses and psychotherapy courses—24% and 26%, respectively—compared with the years before the pandemic.

The steepest increases were among girls. Antidepressant prescriptions rose 137% among girls ages 6 to 12 and 65% among girls ages 13 to 18.

"Youth mental health was already worsening before the pandemic, which further accelerated these trends," said Raman Baweja, professor of psychiatry and behavioral health and of public health sciences at Penn State College of Medicine and the first author of the study. "This suggests that the rise in psychiatric treatment for mental health not only followed the pandemic, but also a decade-long rise in heightened emotional distress among young people, documented by the Centers for Disease Control and Prevention's (CDC) Youth Risk Behavior Survey. But it didn't hit everyone the same. Some groups, girls especially, were affected more."

According to Baweja, existing research had focused on pediatric mental health trends during 2020. However, much less was known about what happened after schools reopened and daily life returned to normal, or whether increases in mental health treatment reflected more children entering care for the first time or more intensive treatment for those already receiving services.

To parse the two, the researchers tracked cases from October 2018 to December 2022 using the TriNetX U.S. Collaborative Network, which provided a research database of pooled de-identified records from 72 U.S. health systems. Geographically, the sample spanned participating health systems in all four U.S. census regions, with roughly 40% of pediatric patients from the South and the rest spread across the Northeast, Midwest and West.

The team analyzed the dataset through two complementary lenses, isolating new patients—children and adolescents receiving a first diagnosis, prescription or therapy after at least a year without a diagnosis or respective treatment—and treatment-engaged patients, defined as those with at least two behavioral health visits within one of the three 17-month phases in the study: pre-pandemic, from October 2018 through February 2020; pandemic, from March 2020 through July 2021; and post-pandemic, from August 2021 through December 2022.

"We evaluated data from patients new to care and those who were already in care, and both showed that adolescent females and antidepressant prescriptions were the driving force of the increase in psychiatric care," Baweja said. Scaling their sample to reflect the national population size, the researchers estimated roughly 40,000 additional girls began antidepressant treatment after the pandemic.

Among all pediatric patients in the treatment-engaged group, most measures of medication use changed only slightly between 2018 and 2022, with antidepressant use climbing from 32% to 36% among adolescent girls.

Medications for attention-deficit/hyperactivity disorder (ADHD) showed smaller increases than antidepressants, with a notable exception among the youngest children in the study. Among those ages 3 to 5, prescriptions for stimulant medications used to treat new ADHD cases rose 147%, although this group started from a lower baseline and remained far below rates in older children.

The CDC recommends parent training in behavior management as the first-line treatment for children with ADHD under age 6 before trying medication, but pandemic-era disruptions may have left families few alternatives, according to Baweja.

He added that the findings reflect patterns of documented diagnoses and treatment among children and adolescents who received care within the health care system, rather than the overall prevalence of mental health conditions among youth.

"Many children experiencing mental health challenges never receive a formal diagnosis or treatment," Baweja said. "Our study captures those who entered the health care system, so these trends reflect changes in health care utilization as much as changes in mental health needs."

The study also found that longstanding racial and ethnic disparities in mental health care persisted throughout the pandemic and recovery period. Although telehealth expanded access for many families, it did not eliminate inequities in care, according to Baweja.

"There was hope that telehealth would narrow longstanding gaps in access, particularly for underserved communities," Baweja said. "Access is not the same for everyone. It is influenced by many factors, including internet connectivity, transportation, family resources, cultural beliefs about mental health and trust in the health care system. Continued efforts are needed to ensure that every child has equitable access to timely, evidence-based care rather than simply assuming technology creates access for all."

The study is one step toward understanding changes in pediatric mental health care among children and adolescents who receive treatment, he added. It fits into a larger line of inquiry from the research team examining how mental health is changing not only for children and adolescents but also for adults.

"Our ongoing research is examining treatment patterns among both children and adults, including how recent changes—such as medication shortages and evolving clinical practices—have influenced treatment patterns, which groups are more or less likely to receive care, and whether disparities in access to evidence-based treatment persist," Baweja said.

More information

Raman Baweja et al, Post-Pandemic Trends in Pediatric Mental Health Treatment: A Nationwide Study, JAACAP Open (2026). DOI: 10.1016/j.jaacop.2026.04.006

Key medical concepts

Attention Deficit Hyperactivity Disorder

Clinical categories

PsychiatryPediatricsChildren's healthPsychology & Mental health Provided by Pennsylvania State University Who's behind this story?

Stephanie Baum

Master's in TESOL from The New School. Passionate about language learning and editing science news on biology and space exploration. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Kids received mental health treatment in record numbers after pandemic, records show (2026, July 9) retrieved 9 July 2026 from https://medicalxpress.com/news/2026-07-kids-mental-health-treatment-pandemic.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.